Skip to main content

Table 2 Patient characteristics in CG and IG at baseline (t0)

From: Determine the impact of a structured pharmacist-led medication review - a controlled intervention study to optimise medication safety for residents in long-term care facilities

Characteristics CG IG p value
Residents, total [n] 104 107
Residents, ownership by private association (5 wards), [n (%)] 40 (38%) 41 (38%) 0.983
Residents, municipal ownership (3 wards), [n (%)] 30 (29%) 34 (32%) 0.644
Residents, welfare ownership (3 wards), [n (%)] 34 (33%) 32 (30%) 0.663
Woman, [n (%)] 75 (72%) 72 (67%) 0.446
Age (years), median (Q25/Q75; Min-Max) 86 (78/90; 66–101) 86 (81/90; 66–100) 0.653
Length of residence (months), median (Q25/Q75; Min-Max) 31 (12/63; 1–414) 28 (12/58; 1–397) 0.437
Residents eligible alone for consent, [n (%)] 29 (28%) 34 (32%) 0.537
Residents required support for drug intake by nursing staff, [n (%)] 61 (59%) 66 (62%) 0.653
Residents with percutaneous endoscopic gastrostomy tubes (drugs must be administered by tube), [n (%)] 2 (2%) 1 (1%) 0.544
No. of chronic medications, median (Q25/Q75; Min-Max) 8 (6/10; 2–18) 7 (5/10; 2–16) 0.210
No. of PRN medications, median (Q25/Q75; Min-Max) 2 (1/3; 1–6) 2 (1/3; 1–8) 0.399
Documented diagnoses, median (Q25/Q75; Min-Max) 15 (10/21; 3–35) 14 (8/20; 3–37) 0.257
Dementia, [n (%)] 69 (66%) 69 (64%) 0.776
Diabetes, [n (%)] 41 (39%) 48 (45%) 0.424
Hypertension, [n (%)] 82 (79%) 87 (81%) 0.654
Renal failure, [n (%)] 24 (23%) 26 (24%) 0.835
Fecal incontinence, [n (%)] 16 (15%) 19 (18%) 0.643
Urinary incontinence, [n (%)] 39 (38%) 31 (29%) 0.188
  1. Abbreviations: Q25 first quartile, Q75 third quartile, CG control group, IG intervention group, Min minimum, Max maximum